Distribution of second primary malignancies suggests a bidirectional effect between breast and endometrial cancer a population-based study

International Journal of Gynecological Cancer

Volumn 19, Issue 8, 2009, Pages 1358-1363

  Cortesi, Laura ^a   De Matteis, Elisabetta ^a   Rashid, Ivan ^b   Cirilli, Claudia ^b   Proietto, Manuela ^a   Rivasi, Francesco ^a   Federico, Massimo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Registro Tumori di Modena ^*  (Italy)

Author keywords

Breast cancer; Cancer registry; Endometrial cancer; Second cancer; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; OVARY CANCER; PRIORITY JOURNAL; SECOND CANCER; THYROID CANCER;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; ITALY; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; REGISTRIES; RISK FACTORS; SURVIVAL RATE; TAMOXIFEN;

EID: 73349136762     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181b9f5d5     Document Type: Article

References (23)

1. Levi F, Te VC, Randimbison L, et al. Cancer risk in women with previous breast cancer. Ann Oncol. 2003;14:71-73.
2. Soerjomataram I, Louwman WJ, de Vries E, et al. Primary malignancy after primary female breast cancer in the south of the Netherlands, 1972-2001. Breast Cancer Res Treat. 2005;93:91-95.
3. Yamazawa K, Miyazawa Y, Suzuki M, et al. Tamoxifen and the risk of endometrial cancer in Japanese women with breast cancer. Surg Today. 2006;36:41-46.
4. Deligdisch L, Kalir T, Cohen CJ, et al. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Oncol.2000;78:181- 186.
5. Cohen I. Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol. 2004;94:256-266.
6. Bergman L, Beelen ML, Gallee MP, et al. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of liver and endometrial cancer risk following tamoxifen. Lancet. 2000;356:881-887.
7. Breslow N. Statistical Methods in Cancer Research. Lyon, France: IARC Scientific Publication; 1987.
8. Gooley TA, Leisenrig W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: new representation of old estimators. Stat Med. 1999;18:695-706.
9. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994; 266:66-71. (Pubitemid 24345325)
10. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789-792.
11. Lynch HT, Lanspa S, Smyrk T, et al. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, part I. Cancer Genet Cytogenet. 1991;53: 143-160.
12. Cybulski C, Gorski B, Huzarski T, et al. CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet. 2004;75:1131-1135. (Pubitemid 39532081)
13. Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003;56: 1038-1045.
14. Levi F, Randimbison L, Te VC, et al. Cancer risk after radiotherapy for breast cancer. Br J Cancer. 2006;95:390-392.
15. Haffty BG. Radiation therapy and the risk of contralateral breast cancer. Int J Radiat Oncol Biol Phys. 2003;56:920-921.
16. Hooning MJ, Aleman BM, Hauptman M, et al. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. J Clin Oncol. 2008;26:5561-5568.
17. Tubiana M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol. 2009;91:4-15.
18. Kaufman EL, Jacobson JS, Hershman DL, et al. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol. 2008;26:392-398.
19. Vilarino-Varela M, Chin YS, Makris A. Current indications for post-mastectomy radiation. Int Semin Surg Oncol. 2009;6:5.
20. Swerdlow AJ, Jones ME. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. J Natl Cancer Inst. 2005;97:375-384.
21. Bland AE, Calingaert B, Secord AA, et al. Relationship between tamoxifen use and high risk endometrial cancer histologic types. Gynecol Oncol. 2009;112:150-154.
22. Kirova YM, De Rycke Y, Gambotti L, et al. Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer. 2008;98:870-874.
23. Geisler JP, Sorosky JI, Duong HL, et al. Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma. Gynecol Oncol. 2001;83:501-503